3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
57
Carcinoma, Hepatocellular
45
Colorectal Neoplasms
18
Esophageal Squamous Cell Carcinoma
10
Cholangiocarcinoma
10
Esophageal Neoplasms
9
Advanced Gastric Cancer
9
Biliary Tract Neoplasms
8
Pancreatic Neoplasms
6
Liver Neoplasms
5
Neoplasms
3
Neoplasm Metastasis
3
Gastrointestinal Neoplasms
3
Gastric Adenocarcinoma
3
Digestive System Neoplasms
3
Recurrence
2
Metastatic Gastric Adenocarcinoma
2
Locally Advanced Gastric Cancer
2
Gastrointestinal Stromal Tumors
2
Advanced Esophagus Cancer
2
Uterine Cervical Neoplasms
1
Stomach Diseases
1
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
1
Peritoneal Metastases From Gastric Cancer
1
Ovarian Neoplasms
1
Locally Advanced or Metastatic Gastric Adenocarcinoma
1
Intestinal Neoplasms
1
Immunotherapy Gastrict Cancer
1
Immunotherapy
1
Hepatic Metastasis of Colorectal Cancer
1
Interventions
sintilimab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Metastatic Gastric Cancer
×
apatinib
×
Gastrointestinal
×
Clear all
NCT04089657
2019-09-13
ASGARD
Fujian Cancer Hospital
Phase 2
Unknown
40 enrolled